Clinical Trial Update: Effect of Prehabilitation During the Conversion Therapy on Postoperative Outcomes in Unresectable Hepatocellular Carcinoma [NA]

View source ↗

Summary

A clinical trial evaluating prehabilitation during conversion therapy for unresectable hepatocellular carcinoma and its effects on postoperative outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Advanced Hepatocellular Carcinoma (HCC), Prehabilitation | NA | Status: NOT_YET_RECRUITING